000			02082 a2200661 4500
005			20250516051654.0
264		0	_c20111220
008			201112s 0 0 eng d
022			_a1536-4844
024	7		_a10.1002/ibd.21582 _2doi
040			_aNLM _beng _cNLM
100	1		_aVos, A C W
245	0	0	_aRisk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. _h[electronic resource]
260			_bInflammatory bowel diseases _cSep 2011
300			_a1837-45 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAzathioprine _xadverse effects
650	0	4	_aCase-Control Studies
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCohort Studies
650	0	4	_aEpstein-Barr Virus Infections _xcomplications
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHerpesvirus 4, Human _xpathogenicity
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aIncidence
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aInflammatory Bowel Diseases _xcomplications
650	0	4	_aLymphoma _xchemically induced
650	0	4	_aMale
650	0	4	_aMercaptopurine _xadverse effects
650	0	4	_aMiddle Aged
650	0	4	_aNetherlands _xepidemiology
650	0	4	_aPrognosis
650	0	4	_aRisk Factors
650	0	4	_aSurvival Rate
650	0	4	_aYoung Adult
700	1		_aBakkal, N
700	1		_aMinnee, R C
700	1		_aCasparie, M K
700	1		_ade Jong, D J
700	1		_aDijkstra, G
700	1		_aStokkers, P
700	1		_avan Bodegraven, A A
700	1		_aPierik, M
700	1		_avan der Woude, C J
700	1		_aOldenburg, B
700	1		_aHommes, D W
773	0		_tInflammatory bowel diseases _gvol. 17 _gno. 9 _gp. 1837-45
856	4	0	_uhttps://doi.org/10.1002/ibd.21582 _zAvailable from publisher's website
999			_c21074872 _d21074872